{"id":"tdap-vaccine-administration","safety":{"commonSideEffects":[{"rate":"20-30","effect":"Injection site pain, redness, or swelling"},{"rate":"1-3","effect":"Fever"},{"rate":"5-10","effect":"Fatigue or malaise"},{"rate":"5-10","effect":"Headache"},{"rate":"5-10","effect":"Muscle aches"}]},"_chembl":{"chemblId":"CHEMBL2108573","moleculeType":"Vaccine component"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The vaccine contains inactivated toxins from Clostridium tetani and Corynebacterium diphtheriae, along with purified acellular components of Bordetella pertussis. Upon administration, these antigens trigger both humoral (antibody) and cell-mediated immune responses, priming the immune system to recognize and neutralize these pathogens if encountered naturally.","oneSentence":"Tdap vaccine stimulates the immune system to produce antibodies and cellular immunity against tetanus toxoid, diphtheria toxoid, and acellular pertussis antigens.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:11:17.680Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of tetanus"},{"name":"Prevention of diphtheria"},{"name":"Prevention of pertussis (whooping cough)"}]},"trialDetails":[{"nctId":"NCT05237947","phase":"PHASE4","title":"Single-Dose HPV Vaccination for the Prevention of Cervical Cancer in Young Adult Women in Costa Rica, The PRISMA ESCUDDO Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2022-03-01","conditions":"Human Papillomavirus-Related Cervical Carcinoma","enrollment":5000},{"nctId":"NCT07097012","phase":"PHASE4","title":"Concurrent Versus Sequential Administration of Tdap and RSV Vaccines in Pregnancy","status":"RECRUITING","sponsor":"Canadian Immunization Research Network","startDate":"2025-10-16","conditions":"RSV, Tdap - Tetanus, Diphtheria and Acellular Pertussis Vaccination, Pregnancy","enrollment":60},{"nctId":"NCT04006457","phase":"PHASE3","title":"Long-Term PF-06651600 for the Treatment of Alopecia Areata","status":"ACTIVE_NOT_RECRUITING","sponsor":"Pfizer","startDate":"2019-07-18","conditions":"Alopecia Areata","enrollment":1052},{"nctId":"NCT07354269","phase":"PHASE4","title":"Phase IV Clinical Study of sIPV Administration in Adolescent and Adult Populations","status":"RECRUITING","sponsor":"Sinovac Biotech Co., Ltd","startDate":"2025-09-26","conditions":"Poliomyelitis","enrollment":180},{"nctId":"NCT06647407","phase":"PHASE1, PHASE2","title":"Safety and Immunogenicity of an Investigational Pentavalent Meningococcal ABCYW Vaccine Against Meningococcal Disease in Children, Toddlers, and Infants","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2024-11-05","conditions":"Meningococcal Immunization, Healthy Volunteers","enrollment":750},{"nctId":"NCT02518555","phase":"PHASE2","title":"Ibrutinib as an Immune Modulating Agent for Patients With Asymptomatic, High-risk CLL/SLL Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Jennifer Woyach","startDate":"2016-01-12","conditions":"Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma","enrollment":42},{"nctId":"NCT06639074","phase":"PHASE2","title":"Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2024-11-08","conditions":"Advanced Fallopian Tube Carcinoma, Advanced Fallopian Tube High Grade Serous Adenocarcinoma, Advanced Ovarian Carcinoma","enrollment":78},{"nctId":"NCT04490018","phase":"PHASE3","title":"Study on a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Compared to a Meningococcal Reference Vaccine, and When Given Alone or With Two Other Vaccines in Healthy Adolescents","status":"COMPLETED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2021-03-16","conditions":"Meningococcal Immunisation, Healthy Volunteers","enrollment":463},{"nctId":"NCT04300192","phase":"PHASE4","title":"Study to Evaluate the Immune Response After Booster Vaccination With Tdap-IPV Vaccine (Against Tetanus, Diphtheria, Pertussis and Poliomyelitis) in Children Who Received Different Pertussis Primary Vaccine Regimens in Republic of South Africa","status":"COMPLETED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2021-01-27","conditions":"Pertussis Immunisation, Diphtheria Immunisation, Tetanus Immunisation","enrollment":273},{"nctId":"NCT04398706","phase":"PHASE2","title":"Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants","status":"COMPLETED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2020-05-22","conditions":"Pneumococcal Immunisation, Diphtheria Immunisation, Tetanus Immunisation","enrollment":852},{"nctId":"NCT05543642","phase":"PHASE4","title":"The COVID-19 VaccinE Response and Co-Administration in Rheumatology Patients (COVER-CoAd)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Oregon Health and Science University","startDate":"2022-10-11","conditions":"Rheumatic Diseases","enrollment":129},{"nctId":"NCT03180034","phase":"PHASE4","title":"Comparing One or Two Doses of the Human Papillomavirus Vaccine for the Prevention of Human Papillomavirus Infection, ESCUDDO Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2017-11-29","conditions":"Human Papillomavirus Infection, Human Papillomavirus-Related Cervical Carcinoma","enrollment":27945},{"nctId":"NCT02783170","phase":"PHASE4","title":"Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women","status":"COMPLETED","sponsor":"Duke University","startDate":"2016-09","conditions":"Pregnancy","enrollment":81},{"nctId":"NCT00505063","phase":"PHASE2","title":"Prospective Trial of Vaccine Responses in Childhood Cancer Survivors","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2007-07-10","conditions":"Childhood Cancer, Multiple Diseases","enrollment":76},{"nctId":"NCT06920069","phase":"PHASE4","title":"Study of Concomitant Administration of the sIPV and DTaP or MMR","status":"NOT_YET_RECRUITING","sponsor":"Institute of Medical Biology, Chinese Academy of Medical Sciences","startDate":"2025-05-15","conditions":"Polio, Diphteria, Tetanus and Pertussis, MMR Vaccine","enrollment":2640},{"nctId":"NCT06891872","phase":"PHASE4","title":"Study of Live Attenuated Varicella Vaccine Co-administered with MMR Vaccine or DTaP Vaccine","status":"NOT_YET_RECRUITING","sponsor":"Sinovac (Dalian) Vaccine Technology Co., Ltd.","startDate":"2025-05","conditions":"Varicella (chickenpox), MMR Vaccine, DTaP Vaccine","enrollment":720},{"nctId":"NCT03562377","phase":"PHASE2","title":"Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2018-07-13","conditions":"Atopic Dermatitis","enrollment":215},{"nctId":"NCT06454812","phase":"NA","title":"The Effect of Mechanical Vibration and Helfer Skin Tap Technique on Procedural Pain in Infants During Vaccination","status":"COMPLETED","sponsor":"Istanbul Medeniyet University","startDate":"2024-07-15","conditions":"Procedural Pain, Nursing Caries, Pain, Acute","enrollment":108},{"nctId":"NCT04444518","phase":"NA","title":"Increasing Influenza and Tdap Vaccination of Pregnant Women","status":"COMPLETED","sponsor":"University of Rochester","startDate":"2019-07-01","conditions":"Immunization; Infection, Pregnancy Related","enrollment":12760},{"nctId":"NCT03165981","phase":"PHASE4","title":"Fever After Simultaneous Versus Sequential Vaccination in Young Children","status":"COMPLETED","sponsor":"Duke University","startDate":"2017-08-25","conditions":"Fever After Vaccination, Fever, Febrile Seizure","enrollment":221},{"nctId":"NCT06135636","phase":"PHASE4","title":"Assessing Interventions to Increase Tdap Acceptance for Non-birthing Partners in Pregnancy","status":"RECRUITING","sponsor":"Women and Infants Hospital of Rhode Island","startDate":"2024-05-28","conditions":"Non-birthing Partner Vaccination in Pregnancy, Tdap - Tetanus, Diphtheria and Acellular Pertussis Vaccination, Vaccine Exposure During Pregnancy","enrollment":150},{"nctId":"NCT04056117","phase":"PHASE1, PHASE2","title":"A Study to Determine If a New Shigella Vaccine is Safe, Induces Immunity and The Best Dose Among Kenyan Infants","status":"COMPLETED","sponsor":"LimmaTech Biologics AG","startDate":"2019-09-02","conditions":"Shigellosis","enrollment":596},{"nctId":"NCT06344065","phase":"PHASE3","title":"Immunogenicity and Safety of Diphtheria, Tetanus, Pertussis (DTaP) Vaccine in 3-month-old Infants","status":"RECRUITING","sponsor":"Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd","startDate":"2023-12-21","conditions":"Healthy Volunteers","enrollment":1584},{"nctId":"NCT03530124","phase":"PHASE4","title":"Apnea in Hospitalized Preterm Infants Following the Administration of Routine Childhood Vaccines","status":"COMPLETED","sponsor":"Duke University","startDate":"2018-07-17","conditions":"Apnea, Apnea Neonatal, Prematurity","enrollment":223},{"nctId":"NCT03673462","phase":"PHASE3","title":"Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers","status":"COMPLETED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2018-09-17","conditions":"Healthy Volunteers (Meningococcal Infection)","enrollment":2797},{"nctId":"NCT03630705","phase":"PHASE3","title":"Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the Russian Federation and Mexico","status":"COMPLETED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2018-10-17","conditions":"Healthy Volunteers (Meningococcal Infection)","enrollment":525},{"nctId":"NCT02458183","phase":"PHASE3","title":"Vaccine -diphthEria -tetaNus -Acellular pertUssis-inactivated polioviruS","status":"COMPLETED","sponsor":"Boryung Pharmaceutical Co., Ltd","startDate":"2015-02-02","conditions":"Diphtheria, Tetanus, Pertussis","enrollment":476},{"nctId":"NCT03958799","phase":"PHASE1","title":"A Study to Describe the Safety Profile and Compare the Immune Response of 4 Different Formulations of an Investigational Tdap Vaccine When Compared to Licensed Tdap Vaccine in Young Adults in Canada","status":"COMPLETED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2019-06-26","conditions":"Tetanus Immunisation (Healthy Volunteers), Diphtheria Immunisation (Healthy Volunteers), Pertussis Immunisation (Healthy Volunteers)","enrollment":71},{"nctId":"NCT02274285","phase":"PHASE3","title":"DTaP-IPV/Hib Vaccine Primary & Booster Vaccinations Versus Co-administration of DTaP-IPV and Hib Vaccine in Japanese Infants","status":"COMPLETED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2014-10","conditions":"Tetanus, Diphtheria, Pertussis","enrollment":424},{"nctId":"NCT02992418","phase":"PHASE3","title":"Study of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Adacel® in Healthy Subjects","status":"TERMINATED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2016-12-19","conditions":"Dengue Fever, Dengue Hemorrhagic Fever","enrollment":688},{"nctId":"NCT02261961","phase":"NA","title":"Immune Function and Muscle Adaptations to Resistance Exercise in Older Adults","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2014-07-23","conditions":"Sarcopenia, Aging, Immune Function","enrollment":59},{"nctId":"NCT04638985","phase":"PHASE4","title":"Evaluation of Immunogenicity and Safety of Combined Immunization of sIPV, DTaP and MMR","status":"UNKNOWN","sponsor":"China National Biotec Group Company Limited","startDate":"2020-11-13","conditions":"Vaccine","enrollment":600},{"nctId":"NCT04636827","phase":"PHASE4","title":"Evaluation of Safety and Immunogenicity of Combined Immunization of sIPV, DTaP and HepA","status":"UNKNOWN","sponsor":"China National Biotec Group Company Limited","startDate":"2020-11-11","conditions":"Vaccination","enrollment":600},{"nctId":"NCT04618640","phase":"PHASE3","title":"To Evaluate the Immunogenicity and Safety of DTaP-IPV Vaccine Administered as a Boosting Dose to Healthy Children of 4-6 Years","status":"UNKNOWN","sponsor":"Boryung Biopharma Co., Ltd.","startDate":"2019-12-26","conditions":"Diphtheria, Tetanus, Pertussis","enrollment":249},{"nctId":"NCT04424693","phase":"PHASE4","title":"Comparing the Incidence of Preeclampsia Between Pregnant Women Receiving Tdap Vaccinations at Week 28 or at Week 36","status":"UNKNOWN","sponsor":"Institute of Arthritis Research","startDate":"2020-12-01","conditions":"Pre-Eclampsia, Diphtheria, Tetanus and Pertussis Vaccine Reaction","enrollment":1600},{"nctId":"NCT00489970","phase":"PHASE3","title":"Persistence Study of GSK Biologicals' Tdap Vaccine 1, 3, 5 and 9 Years Following Administration as an Initial Single Dose in Healthy Young Adults and to Evaluate the Immunogenicity and Safety of Boostrix as a Second Dose of Tdap, When Administered at Year 9","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2007-06-01","conditions":"Acellular Pertussis, Tetanus, Diphtheria","enrollment":1954},{"nctId":"NCT04053010","phase":"PHASE4","title":"Clinic Trial to Evaluate the Safety and Immunogenicity of Combined Immunization of sIPV and DTaP","status":"UNKNOWN","sponsor":"China National Biotec Group Company Limited","startDate":"2019-08-10","conditions":"Vaccination","enrollment":702},{"nctId":"NCT00385255","phase":"PHASE3","title":"Immunogenicity, Safety of GSKs Tdap Vaccine Boostrix When Coadministered With GSKs Influenza Vaccine Fluarix in Adults","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2006-10-23","conditions":"Acellular Pertussis, Diphtheria, Tetanus","enrollment":1726},{"nctId":"NCT01480258","phase":"PHASE3","title":"Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 4, and 11 to 12 Months (V419-008)","status":"COMPLETED","sponsor":"MCM Vaccines B.V.","startDate":"2011-11-23","conditions":"Bacterial Infections, Virus Diseases","enrollment":1315},{"nctId":"NCT01839188","phase":"PHASE3","title":"Spanish Mixed HEXA/PENTA/HEXA Schedule (V419-010)","status":"COMPLETED","sponsor":"MCM Vaccines B.V.","startDate":"2013-05-01","conditions":"Neisseria Meningitidis, Bacterial Infections, Virus Diseases","enrollment":385},{"nctId":"NCT00446875","phase":"NA","title":"Analgesic Properties of Oral Sucrose During Immunizations","status":"COMPLETED","sponsor":"Milton S. Hershey Medical Center","startDate":"2007-01","conditions":"Procedural Pain","enrollment":98},{"nctId":"NCT01738477","phase":"PHASE3","title":"Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Previously Boosted Young Adults","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2013-01-31","conditions":"Tetanus, Acellular Pertussis, Diphtheria","enrollment":165},{"nctId":"NCT03304275","phase":"NA","title":"The Feasibility of Pertussis Immunization in a Canadian Emergency Department","status":"COMPLETED","sponsor":"University of Prince Edward Island","startDate":"2017-07-10","conditions":"Pertussis","enrollment":644},{"nctId":"NCT01839175","phase":"PHASE3","title":"Concomitant Administration of a New Hexavalent Vaccine With a Meningococcal Serogroup C Conjugate Vaccine in Healthy Infants During Primary Series Immunisation Followed by Booster Vaccination","status":"COMPLETED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2013-04","conditions":"Neisseria Meningitidis, Bacterial Infections, Virus Diseases","enrollment":350},{"nctId":"NCT02765126","phase":"NA","title":"Heterologous Effect of Diptheria, Tetanus, Acellular Pertussis Vaccination on Influenza Challenge in the Elderly","status":"UNKNOWN","sponsor":"Clifford Craig Medical Research Trust","startDate":"2016-05","conditions":"Heterologous Effects of Vaccines","enrollment":450},{"nctId":"NCT02543918","phase":"PHASE1","title":"A Study of the Immune Response to Vaccines and Ixekizumab (LY2439821) in Healthy Participants","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2015-09","conditions":"Healthy","enrollment":84},{"nctId":"NCT02808637","phase":"NA","title":"Vaccine-Related Pain in Infants","status":"COMPLETED","sponsor":"Çankırı Karatekin University","startDate":"2015-04","conditions":"Pain","enrollment":128},{"nctId":"NCT01529645","phase":"PHASE1","title":"Safety and Dose Ranging Study of Acellular Pertussis and Acellular Pertussis -Tetanus-Diphtheria Booster Vaccines in Healthy Adults Ages 18 to 40 Years","status":"COMPLETED","sponsor":"Novartis Vaccines","startDate":"2012-03","conditions":"Pertussis, Whooping Cough, Tetanus","enrollment":420},{"nctId":"NCT02382913","phase":"PHASE1","title":"Persistency Study After aP / Tdap Booster Vaccines in Adult Subjects (V113_01 Extension 1)","status":"COMPLETED","sponsor":"Novartis","startDate":"2015-04","conditions":"Pertussis","enrollment":315},{"nctId":"NCT01096134","phase":"NA","title":"Mother - Daughter Initiative (MDI) in Cervical Cancer Prevention","status":"COMPLETED","sponsor":"Jhpiego","startDate":"2011-01","conditions":"Cervical Cancer","enrollment":8000},{"nctId":"NCT01003431","phase":"PHASE3","title":"A Study of the Immunogenicity and Safety of Whole-Cell Pertussis Containing Vaccine Administered Concomitantly With RotaTeq™ (V260) or Rotarix™ (V260-036)(WITHDRAWN)","status":"WITHDRAWN","sponsor":"Merck Sharp & Dohme LLC","startDate":"2009-12","conditions":"Rotavirus Gastroenteritis, Diphtheria, Tetanus","enrollment":""},{"nctId":"NCT00329901","phase":"PHASE3","title":"Immunogenicity and Safety of the Concomitant Administration of a Tdap Vaccine and Meningococcal ACWY Conjugate Vaccine in Healthy Subjects Aged 11-25 Years","status":"COMPLETED","sponsor":"Novartis Vaccines","startDate":"2006-04","conditions":"Meningococcal Disease, Meningococcal Meningitis","enrollment":1072},{"nctId":"NCT00712959","phase":"PHASE4","title":"Immune Responses in Adults to Revaccination With ADACEL® 10 Years After a Previous Dose","status":"COMPLETED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2008-06","conditions":"Pertussis, Tetanus, Diphtheria","enrollment":769},{"nctId":"NCT01445743","phase":"PHASE2","title":"Immunogenicity and Safety of an Acellular DPT Vaccine During Pregnancy","status":"COMPLETED","sponsor":"Hospital Universitario Dr. Jose E. Gonzalez","startDate":"2011-09","conditions":"Pregnancy","enrollment":204},{"nctId":"NCT01651247","phase":"","title":"Assessment of the Serologic Response to Porcine Circovirus Type 1 (PCV-1) in the Serum of Infants and Toddlers, Following Administration of IPV (Inactivated Poliovirus Vaccine)-Containing Vaccines","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2010-05","conditions":"Presence of Materials From PCV-1","enrollment":1}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":7,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["BOOSTRIX","Tetanus-diphtheria-acellular pertussis"],"phase":"marketed","status":"active","brandName":"Tdap Vaccine Administration","genericName":"Tdap Vaccine Administration","companyName":"Institute of Arthritis Research","companyId":"institute-of-arthritis-research","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Tdap vaccine stimulates the immune system to produce antibodies and cellular immunity against tetanus toxoid, diphtheria toxoid, and acellular pertussis antigens. Used for Prevention of tetanus, Prevention of diphtheria, Prevention of pertussis (whooping cough).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}